The dual role of GLP-1 RAs in controlling blood sugar and promoting weight loss has made them a popular option for managing T2DM and obesity, conditions that are often co-existing and mutually aggravating. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.